Latest Fentanyl Stories
In response to a recent report published by The Tennessean, Drug Rehab Nashville offers new incentive programs for victims of drug overdoses. Nashville, Tennessee
Clinical Data from Two Different Development Programs Highlight Efficacy and Tolerability of Sublingual Sufentanil in Out-patient and In-patient Surgical Populations REDWOOD CITY,
- June re-launch with significantly expanded commercial resources NEWARK, Calif., April 2, 2015 /PRNewswire/ -- Depomed, Inc.
-- Remimazolam is an Ultra-Short-Acting Sedative/Anesthetic -- MAHWAH, N.J., March 31, 2015 /PRNewswire/ -- PAION, Inc., a wholly owned subsidiary of PAION AG, today announced the initiation
AcelRx Announces Restructuring to Focus on Regulatory Approval of Zalviso and Clinical Development of ARX-04 REDWOOD CITY, Calif., March 20, 2015 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc.
NEWARK, Calif., March 17, 2015 /PRNewswire/ -- Depomed, Inc.
SAP301 Trial to Study Sufentanil Sublingual Single-Dose Tablet for the Treatment of Moderate-to-Severe Acute Pain REDWOOD CITY, Calif., March 16, 2015 /PRNewswire/ -- AcelRx Pharmaceuticals,
NEWARK, Calif., March 12, 2015 /PRNewswire/ -- Depomed, Inc.
POTTERS BAR, England and PITTSBURGH, March 11, 2015 /PRNewswire/ -- Mylan N.V. (Nasdaq: MYL) and Mylan Inc. today announced the U.S.
REDWOOD CITY, Calif., March 9, 2015 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc.
- Growing in low tufty patches.